0001193125-25-201418.txt : 20250911 0001193125-25-201418.hdr.sgml : 20250911 20250911171207 ACCESSION NUMBER: 0001193125-25-201418 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 10 CONFORMED PERIOD OF REPORT: 20250905 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers FILED AS OF DATE: 20250911 DATE AS OF CHANGE: 20250911 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ACHIEVE LIFE SCIENCES, INC. CENTRAL INDEX KEY: 0000949858 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] ORGANIZATION NAME: 03 Life Sciences EIN: 954343413 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 033-80623 FILM NUMBER: 251309284 BUSINESS ADDRESS: STREET 1: 22722 29TH DR. SE STREET 2: SUITE 100 CITY: SEATTLE STATE: WA ZIP: 98021 BUSINESS PHONE: 425-686-1500 MAIL ADDRESS: STREET 1: 22722 29TH DR. SE STREET 2: SUITE 100 CITY: SEATTLE STATE: WA ZIP: 98021 FORMER COMPANY: FORMER CONFORMED NAME: ONCOGENEX PHARMACEUTICALS, INC. DATE OF NAME CHANGE: 20080821 FORMER COMPANY: FORMER CONFORMED NAME: SONUS PHARMACEUTICALS INC DATE OF NAME CHANGE: 19950825 8-K 1 achv-20250905.htm 8-K 8-K
0000949858false0000949858dei:OtherAddressMember2025-09-052025-09-0500009498582025-09-052025-09-05

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): September 5, 2025

ACHIEVE LIFE SCIENCES, INC.

(Exact name of Registrant as Specified in Its Charter)

Delaware

033-80623

95-4343413

(State or Other Jurisdiction

of Incorporation)

(Commission

File Number)

(IRS Employer

Identification No.)

22722 29th Drive SE, Suite 100

Bothell, WA

 

98021

1040 West Georgia, Suite 1030

Vancouver, BC, Canada

V6E 4H1

(Address of Principal Executive Offices)

(Zip Code)

Registrant’s Telephone Number, Including Area Code: (604) 210-2217

N/A

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol

Name of exchange on which registered

Common Stock, par value $0.001 per share

ACHV

The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On September 5, 2025, Dr. Cindy Jacobs informed the board of directors (the “Board”) of Achieve Life Sciences, Inc. (the “Company”), that she has elected to resign from her role as the Company’s Chief Medical Officer and President, effective as of October 6, 2025. The Company is in the process of negotiating the terms of a consulting agreement with Dr. Jacobs pursuant to which Dr. Jacobs will continue to provide advisory services to the Company.

 

 

 

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

ACHIEVE LIFE SCIENCES, INC.

 

Date: September 11, 2025

 

/s/ MARK OKI

 

Mark Oki

Chief Financial Officer (Principal Financial Officer)

 

 

 EX-101.SCH 2 achv-20250905.xsd XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT 75000 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Amendment Flag Amendment Flag Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Entity Address, Postal Zip Code Entity Address, Postal Zip Code Entity Address, Address Line One Entity Address Address Line 1 Document Type Document Type Entity Central Index Key Entity Central Index Key Entity Address, State or Province Entity Address, State or Province Pre-commencement Tender Offer Pre-commencement Tender Offer Document Information [Line Items] Entity Address, Address Line Two Entity Address Address Line 2 Entity Address, City or Town Entity Address, City or Town Security Exchange Name Security Exchange Name Written Communications Written Communications Document Period End Date Document Period End Date Entity File Number Securities Act File Number Cover [Abstract] Other Address [Member] Principal Address Title of 12(b) Security Title of 12(b) Security Document Information [Table] Trading Symbol Trading Symbol Address Type [Domain] Entity Addresses, Address Type [Axis] Entity Registrant Name Entity Registrant Name City Area Code City Area Code Soliciting Material Soliciting Material Entity Address, Country Entity Address, Country Entity Tax Identification Number Entity Tax Identification Number Local Phone Number Local Phone Number Entity Emerging Growth Company Entity Emerging Growth Company XML 4 R1.htm IDEA: XBRL DOCUMENT v3.25.2
Document and Entity Information
Sep. 05, 2025
Document Information [Line Items]  
Document Type 8-K
Amendment Flag false
Document Period End Date Sep. 05, 2025
Entity Registrant Name ACHIEVE LIFE SCIENCES, INC.
Entity Central Index Key 0000949858
Entity Emerging Growth Company false
Entity File Number 033-80623
Entity Incorporation, State or Country Code DE
Entity Tax Identification Number 95-4343413
Entity Address Address Line 1 22722 29th Drive SE
Entity Address Address Line 2 Suite 100
Entity Address, City or Town Bothell
Entity Address, State or Province WA
Entity Address, Postal Zip Code 98021
City Area Code 604
Local Phone Number 210-2217
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, par value $0.001 per share
Trading Symbol ACHV
Security Exchange Name NASDAQ
Principal Address  
Document Information [Line Items]  
Entity Address Address Line 1 1040 West Georgia
Entity Address Address Line 2 Suite 1030
Entity Address, City or Town Vancouver
Entity Address, State or Province BC
Entity Address, Country CA
Entity Address, Postal Zip Code V6E 4H1
XML 5 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 6 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ .report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } .report table.authRefData a { display: block; font-weight: bold; } .report table.authRefData p { margin-top: 0px; } .report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } .report table.authRefData .hide a:hover { background-color: #2F4497; } .report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } .report table.authRefData table{ font-size: 1em; } /* Report Styles */ .pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ .report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } .report hr { border: 1px solid #acf; } /* Top labels */ .report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } .report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } .report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } .report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } .report td.pl div.a { width: 200px; } .report td.pl a:hover { background-color: #ffc; } /* Header rows... */ .report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ .report .rc { background-color: #f0f0f0; } /* Even rows... */ .report .re, .report .reu { background-color: #def; } .report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ .report .ro, .report .rou { background-color: white; } .report .rou td { border-bottom: 1px solid black; } .report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ .report .fn { white-space: nowrap; } /* styles for numeric types */ .report .num, .report .nump { text-align: right; white-space: nowrap; } .report .nump { padding-left: 2em; } .report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ .report .text { text-align: left; white-space: normal; } .report .text .big { margin-bottom: 1em; width: 17em; } .report .text .more { display: none; } .report .text .note { font-style: italic; font-weight: bold; } .report .text .small { width: 10em; } .report sup { font-style: italic; } .report .outerFootnotes { font-size: 1em; } XML 8 FilingSummary.xml IDEA: XBRL DOCUMENT 3.25.2 html 2 24 1 false 1 0 false 0 false false R1.htm 75000 - Document - Document and Entity Information Sheet http://ir.achievelifesciences.com/20250905/taxonomy/role/Role_DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports achv-20250905.htm achv-20250905.xsd http://xbrl.sec.gov/dei/2025 false false JSON 10 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "achv-20250905.htm": { "nsprefix": "achv", "nsuri": "http://ir.achievelifesciences.com/20250905", "dts": { "inline": { "local": [ "achv-20250905.htm" ] }, "schema": { "local": [ "achv-20250905.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/arcrole/esma-arcrole-2018-11-21.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd", "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd", "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd", "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd", "https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd", "https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd", "https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd", "https://xbrl.sec.gov/country/2025/country-2025.xsd", "https://xbrl.sec.gov/dei/2025/dei-2025.xsd", "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd" ] } }, "keyStandard": 24, "keyCustom": 0, "axisStandard": 1, "axisCustom": 0, "memberStandard": 1, "memberCustom": 0, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2025": 2 }, "contextCount": 2, "entityCount": 1, "segmentCount": 1, "elementCount": 30, "unitCount": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2025": 29 }, "report": { "R1": { "role": "http://ir.achievelifesciences.com/20250905/taxonomy/role/Role_DocumentDocumentAndEntityInformation", "longName": "75000 - Document - Document and Entity Information", "shortName": "Document and Entity Information", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "C_7c354c48-2fd8-44ba-96bc-576d84a68be0", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "div", "body", "html" ], "reportCount": 1, "baseRef": "achv-20250905.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_7c354c48-2fd8-44ba-96bc-576d84a68be0", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "div", "body", "html" ], "reportCount": 1, "baseRef": "achv-20250905.htm", "first": true, "unique": true } } }, "tag": { "dei_AddressTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "AddressTypeDomain", "presentation": [ "http://ir.achievelifesciences.com/20250905/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Address Type [Domain]", "documentation": "An entity may have several addresses for different purposes and this domain represents all such types." } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "AmendmentFlag", "presentation": [ "http://ir.achievelifesciences.com/20250905/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Amendment Flag", "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "CityAreaCode", "presentation": [ "http://ir.achievelifesciences.com/20250905/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "City Area Code", "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_DocumentInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentInformationLineItems", "presentation": [ "http://ir.achievelifesciences.com/20250905/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Information [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "dei_DocumentInformationTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentInformationTable", "presentation": [ "http://ir.achievelifesciences.com/20250905/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Information [Table]", "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentPeriodEndDate", "presentation": [ "http://ir.achievelifesciences.com/20250905/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Document Period End Date", "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentType", "presentation": [ "http://ir.achievelifesciences.com/20250905/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Document Type", "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityAddressAddressLine1", "presentation": [ "http://ir.achievelifesciences.com/20250905/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "terseLabel": "Entity Address Address Line 1", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityAddressAddressLine2", "presentation": [ "http://ir.achievelifesciences.com/20250905/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "terseLabel": "Entity Address Address Line 2", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityAddressCityOrTown", "presentation": [ "http://ir.achievelifesciences.com/20250905/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, City or Town", "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityAddressCountry", "presentation": [ "http://ir.achievelifesciences.com/20250905/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Country", "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://ir.achievelifesciences.com/20250905/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Postal Zip Code", "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://ir.achievelifesciences.com/20250905/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, State or Province", "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityAddressesAddressTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityAddressesAddressTypeAxis", "presentation": [ "http://ir.achievelifesciences.com/20250905/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Addresses, Address Type [Axis]", "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityCentralIndexKey", "presentation": [ "http://ir.achievelifesciences.com/20250905/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Central Index Key", "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r1" ] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://ir.achievelifesciences.com/20250905/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Emerging Growth Company", "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r1" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityFileNumber", "presentation": [ "http://ir.achievelifesciences.com/20250905/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity File Number", "label": "Securities Act File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://ir.achievelifesciences.com/20250905/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Incorporation, State or Country Code", "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityRegistrantName", "presentation": [ "http://ir.achievelifesciences.com/20250905/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Registrant Name", "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r1" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://ir.achievelifesciences.com/20250905/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Tax Identification Number", "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r1" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "LocalPhoneNumber", "presentation": [ "http://ir.achievelifesciences.com/20250905/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Local Phone Number", "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_OtherAddressMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "OtherAddressMember", "presentation": [ "http://ir.achievelifesciences.com/20250905/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Other Address [Member]", "terseLabel": "Principal Address", "documentation": "Other address for entity" } } }, "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://ir.achievelifesciences.com/20250905/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Pre-commencement Issuer Tender Offer", "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r3" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "PreCommencementTenderOffer", "presentation": [ "http://ir.achievelifesciences.com/20250905/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Pre-commencement Tender Offer", "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r5" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "Security12bTitle", "presentation": [ "http://ir.achievelifesciences.com/20250905/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r0" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "SecurityExchangeName", "presentation": [ "http://ir.achievelifesciences.com/20250905/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Security Exchange Name", "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r2" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "SolicitingMaterial", "presentation": [ "http://ir.achievelifesciences.com/20250905/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Soliciting Material", "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r4" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "TradingSymbol", "presentation": [ "http://ir.achievelifesciences.com/20250905/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Symbol", "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "WrittenCommunications", "presentation": [ "http://ir.achievelifesciences.com/20250905/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Written Communications", "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r6" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14a", "Subsection": "12" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" } } } ZIP 11 0001193125-25-201418-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001193125-25-201418-xbrl.zip M4$L#!!0 ( (*)*UN>;K,HA14 %N_ 1 86-H=BTR,#(U,#DP-2YH M=&WM/6MWXK:VW_LK=-+;3F;=R-CRFV3FK)1A6DYGDEDA;<^Z7\Z2+3GHC+&I M;1+HK[];LDT@(9,'AI"4MJL!]-YO;6UM'?US,HS1)<]RD2;OWAB:_@;Q)$R9 M2"[>O3GN=WJ]-_]\_]W1/S!&'S[V3M )OT+'82$N^0>1AW&:CS..]ON?WZ)> M$HN$HW__=/8)?4C#\9 G!<)H4!2C=JMU=76EL4@D>1J/"Q@KU\)TV$(85YUW M,D[E[^@#+3AJ$YW86/>Q89P;5MO0VX:K&<3R_U?7V[H^URP=33-Q,2C0?O@6 MR58P=I+P..93]%$D- D%C5&_'O4 IAEJZ#B.T9ELEJ,SGO/LDC.M['10 #P M)DG^;F]NZE>FEF87+=5EFX4+586M4N MJQ;S5<7"!.9KFRV 8P%+XW5]@/S7;U27Q0'-9]4GM^HOK$^6UE7%Y*Y^#3D- MB7*)\;IZDB8G@/E,A,N;L2)K%=,1;T%%G)0U9[/*Q;(YP0J,UK\_?^J' SZD M^.;2&;\!_9R'VD5ZV8*"EB2(V4KRU"*&^RVHEC5F/1<9EG/-[UD*#&)AW<"F M4;>DX>!RUDAD&GP7_)+'(N)Y*("_>$G^/5RKF'=*C*: MY%&:#17'2%0 KWASXT,_R^?\K4X(P3K!AE-W,BZR.V'EMZ!T[_UWZ&C *8._ MZ*@01_C7HU;Y4?XXY 55$@#S/\<"8-))DP+D CX'P.VAL/SV;J_@DZ*E MV*HE.VU5O1X%*9NBO)C&_-W>B#(IE=K>:'(XI-F%2-IT7*3_$,-1F@%)%(=_ M 7$P/FGKA_B*!U]%@66_.!=_<4S9?\=Y 9)$_^%PE.9"+KJ=\9A*47:XIV;+ MQ&4]&!/Y**932<^R]$A,VG)./"L_"L9XHCY>$SP2[-W>Q__8S J(ZQ+LVHZ) M+>(;F/JN@XG+@\!A 7-=?P\E="A'X:+=30!)A'SL&4%%/M.$&+;=9AG4<<+N+[W7H=_?,OW;.^HM3"UY3/E M84!,W[9PX WNT! M@;8C,>$,1S0&N?1>_;DUZ]8BK#,>\4QQS_LC*:/:N1(), .D9%9;LN.[O1PH M(I;R0?TVR.0$)4?BFMVT2(;4M/E2+N_T?EW$X\W& M=7^]E MG=-BP+.JI.SEJ+6T\_?UK&9S:"U;\ APF++9? N:%5*WOZ]5NV[/^IF5S2#' M[JA:E]3?ZT%:"]BZ WD/8J+U(F_[(-5:I/K6G*1K@4"\*1AK&4L.AR+! RZ- MJ+:NV2)9*E87^PACFH,V'5)H6LE^]1>^\VSOYA#V\AY'=;T(6BKA#E)]5%0Z M 1?I"!2 *HOH4,33]CGP0JX,U[-T2).Z8I 613J$NDI)T%A<).V81X4<(Q_1 MI![F:B *CN&7D+='&<=7&1T=SHT-0W]K-%7VE6>)U%U*G4C 70E6#$ $%C4< M8-0?OS<<_?"H)0<'P(WFEAJD&6!$K8UHQ!X5B*7C(.:'E5)4);.9+(6)=<\\ MOP&5$.;'LT?"Y;[Q&H'+W5_\]\^X'U#\_/N_V:ZALY4S1(W'V9+;=ZQH*A&A:-85O-]3XAOSX:?[WJY>/IV6>TC*@? M,=K>\@UG:)FAZ40F-@P3#' G@*UGI(?8XJX=F=P)J$V?MJ^\WJ36GD?E8-A2 M$"LG245N-W>\+TX/[(3)JQ,FS>D?L'O.NB?GZ*S[Y?3L_ 6JRK^?E?-EG.5C MFA2H2%&?A^I,QC!1FB'#WF=O=SA\ 3A,(U0,N$3?.!.%@%ZZDW! DPLNS^X0 M%!N^:;TJ5)JO5H:J U% V1F7YQQHO_[.:18#:@O$+^5):Z:*.7O;OL]ZNV]J M=UAOGF.&@4PS-\)6Z%*+^[I.S7!53B]/I,[XAMV33K=_@'HG'6UCK-S@D:/.@()ZS=9A #>WI%(V M+/H[)(-V:!#S>E;5(N2$561-C5PY,]DU+$M6QS&=IN.J2CF*KVOZ#W5U6%Q, M1SEOYWQ$,[#6:NBH.+VRF8JWD>-G]>"7(A>!B$$GM.L.ZEI0C(, K5P! M'G"0WI XLE;]4TD%LYX7F62TC!8]S?/-'Q8FHC=3FS%QY$U2:1KTD3#/8TJGPO'X!?-1)QTF133LI6]P2 MR9!!&1E2\%&67LI^FML+/6R'RF-Z13-^CS$D)6VK8/>3W'T45B+O841V1\ ( MV0+I_G@]]2#HS?,)\33[.5C6UHBW)1RK1RXUB!=AW3<=X%C#QE[(":8ALP(K M!N@LIX1C8 M@F/JF!0[@6."6O0B)VK(,7!.)[TJ;#)4&O 9&,N7$;[PK_$HSMJ99XO"WMM. M9\+#/ 3*[I)G7RHX&OUKG(F<"74HMG3_N!FXR WA,T,FC=""@?IVIV5V1M[K MX?M..AR*/'\(FZ\-"EO Y=*B1:7FW3'XJS8C7S2W]L[ZJ#LE4WEGZIEOW M9?/CHDF,3E)M.5NNRP:%UT^EVZ%@;.[>RM^5ZV>0)#M(/AF2WR1S M_7%D?GLUC9+]@\7U.G;Y"^=*_%50%P:N*:!&24.MCQ.L><#WKCM>2ST;>82OU%L=>#C:7:>7FWV MC.BGM!CP.'Y1G&2:1L@C,\ &\1FV(N9BG^DA)EZH>S[WKVG)4CW?9= M/PRJ0$;?=W%@NP6'3XDZ> N#HUJB7AZA^FYF6;]LZ#K@EY87I8>JZ' >V;W#=\=S O6V6-82G MYS&BS>>PHALRHFGDV2P@,@PK"K%%+!.#>(X $688,L,*R9)SZ56P]4Q&].\T M"=/QY9R7\R7P4D1L+[0<'\QH"\QH #KV Q+BT'5<[H(RI7;0*':>TXS^J?.B M< -;',.@MG+W\\(]Q9N"WA;&;!DV(Y9A!9C9)E@RMD>Q%T0,&X%IZH:C?!F-ZZX:N2S'CMH>M"'1L M$+B@63W;8CZC/C=63F\ M65@F['DMR[1Q8'@1=BF+* T.* Y"= 9\/"KRBE&1Z,L'65"WHL)T@D* M>)Q>2<*7A9(?D(=_19&(I0TF357+ MJD$:P-++X-8JAUEVG95C#/UDB";3NBQ*8QAW_3Y1/[]]Z!&D M:1Q0D&(%D,8Z_3@_?N^[EG7X&-?H:Z6F1N%:X1FH91[1:#271/5L#(+-(G:E MOVXDYI3Y./<-%W4^GB%BZAI47,E2;"*<_C'^IITVVFFCG39:01OYM@7FL3R5 MXS;!5DC@$]%]S$/;();MA)Z^[U31-I!2HW"]1C(: M5EB^K8<,BV*#S*FBA<30,T5DZ5I9+7J@N\IQUZB*B64_)O^>[FKUU">Y> ML@!I6!=Y#F&$,8(C$JBC"XY]CW-,+"^DANOZQ+L=#?9(7?0EXW)7))_<5.^T M2.]0=AI%\@' G4YZ?I)J%*Z ;!S.8?O>?9)A,4SV@[Z*.(CL=M;4ZRO$LUR2^CKT@X-BBS,%!Y'F8 M[335EA'6,VLJ,(ZL_?!AFJJJ^Z(TU0HOZFS3T>6BB*MGK\)!^9#\BLINAXDG M8B*C*L"V--EV2'@6))Q4C];PVN0 _05S -:X5G*/O_!B[(3AT_)BZS3R0TO= MEPJQY1H$!YZK8YU9H4VM@'#BK'R&4]HQ4X,$2A:NTQB6FQ\@J'Z1AE\/$-@& MZ)+&8X[^!Z"N&V@$]FX^6-N##Z^%*FS',7S/(3BR=%=Z4P/8I-H$^[YO^3Z4 M>O[*5%$)XU(6KY,DCCN__+Y#=R/NMX=I6=B#/. =SSN<)"RT Y]X'?+,2(5U$IWNA^H#G-&_US#+8.G MH*[,NZ2$)_I,LZ^\0)\^=9K;F+^2F.)>PJ1WA:-@BD(57PP3_PI6#%>Y]F\$ M_XH&88":1_*A/QG@7WIZ2(#)DKZ6O:D\ZU1Z?:[;S76K;:M7X6]$ M>MT[R.BQ-\*>=,9*_ #^8]@((Q]$,]&QYU,/F[:O4V;HEN=8S60BJU?YLUID MIUSC>ES73P!/TR[O;:"K#3Y:ODWLU(N^(9L/0"(O%?3BU@6/ 8AQ'O.P #&> MI,HW.\ZYJ@4+KZZ10,U<*'_M2#T2+NE9C15/Y>!7 H:6O)S 0J DXY2:;:"39[YE M1C1BCPK$TC%86O?QTN:@LB1-)Q.7TBH\@K_U?/Y2KXM,VN0PBOD$,Y&5Q"F] M\N-A M4YE+8][#/H/I9$/9;>8?6[F1B41_+-9NAD"\ZS&-WHFXPT0M>.N PC0 ;1I?T6E>'6?,T\3"OEJA])I*YK!M MR'WS=J!4<5J3"-T8&ZH3!XE,:%X?,LF_\%W& ]S@4GL)P->0"]=93(2[BDUP MQR7RYF*&>@4?(EO3B88^R./&8IPI#_8')2P9R3 M*&8SLMJ7O\N4,40__$D6J\_&H;+HCL.!X)< MZJ8',!@M4 X5YHU6L!DSG@,<492E0R3=&%D:<^F>D'W-=:+2UW1@[ A]YM(\ MCFMB!..5H2^R&_G8SP'B420YX%+U C,^A55)@#@E0#1T?MUS>>%:C04&;5@E MQTK GBP$51:O+ *=,E0%5&XS\W&L2NA%QLO(%V5"2S!7 )XWB_QR#9)_M"AYPO'.PS&49TG&NS$\A0TQEKBI][*)^I]<]Z73[L.$\Z6AKC]?;47]SU/^B MB? #"/WVG'/%,$IGPB;9>_%L1I=/V%=1L%O#^#NBF5].*V^AS\=GOZ+37WL[ M4?6"1-5.43\%CC)R#YU^%:^&?TMO\\=9'$3M;]Z_?CSA5F&#B>DWZA_=.0QW M#L.-.PR/6D'*IN^_.VH-BF'\_O\!4$L#!!0 ( (*)*UMQSBKW7@T +K( M 1 86-H=BTR,#(U,#DP-2YX9-$&3 M039I%\&F39&DF,$6BT*6Z)@82O12?B=3[P< MGL/#?OS]T<7@'E(?$>]X,!Z.!@!Z-G&0=W<\^'YCG-Z<75P,?C]Y]?$?A@'. M/U]\!5_A SBU W0/SY%O8^(O*01O;KZ\!7_^Z_H2W-ASZ%K@G-A+%WH!,, \ M"!9'IOGP\#!T9LCS"5X&K#E_:!/7!(81"S^CT.+/P;D50' T&4WVC=&A,1[? MCM\?C4='XX/AWNC@X)^CT=%HE*I&%D\4W \QFD'?1HPS&.G# 8P.1_L#8 4!1=-E #\3ZI[#F;7$P?%@ MZ?U_:;%:"#J,:@PY1YD"J=?LVWC^D1-0(WA:0#]IGC/Y.*5X2.B=R5Z;_#5O M^;TQ&AM[8U$3>DMWDM1*:K""(Q,^!M#ST11#@Q>#-.3>-R:\"T35&1&9)A_V MXNJCL?GGE\OH0XO"&'E_R0&R\GLF?SVU?"B*+WWCSK(628V9Y4_#TO&+D,>$ M 8BR6OC0'MZ1>Y.]R!3D+YU IO%HWXQ>IHNB$L"LGP:LZR2 V?>^7^_[Q^T4 MB(EI'!\>'IKAV\')*P#";H?"<*6^"/Q<+% WHQ$ M3]@SWE..*,'PEH$'_,?WZXMUAJ496(_$(^Z3R2N;U^R/GV*I$G^?>LXG+T#! MTP5KFKHAI@% ;#*L7EP@%I@=R%8^%&IWL#_BZU=ZA4Q^6IX#(F$@)>VCF9>1 MD[[TH7/EG82_%Y0M9U[$Y"5[$%>.BY14M"UL+_'Z]9YA*:O%#\6'RWY.,?I# MAG$\':8+6-3F-:_A#,0_TQ\]Z=/("TP'N69G&I"QWWSM)9[A1*O^ACB5=N#SHAI!G/8A.%"=PKI MIH!E,AI!.V="J;V<0B,A:4/,)9*V0&2D@7_*VS99#/.+-'B 3F0 M&IY%*7FH0CJF-*G+A1OQ/Y@VXP_,_#=FDX:)G2F* MN9U )-^[FLGPFOWCI^# )I19("$+-VPE@V=DZ07TZ8PX4,@/ 1\/JM8RVU'@ ME'U,)]S28>M. C7[OB50WRBCPG5Y%^=-7_C^$M);_EWIU6SV/)12.%=6:0EZ M]&E/'8<9-?XWPO8J^+]H4=H/I(6[@!O_Q085'*]"FRG;$E@Q]W"+3((O\[I5 M_LY8J]3"%ZRW/?X'/BFYRY?KXB.'$\T5_4;)/8J\!:7?.5^\FQE@K;'?P:@7 M72^U&/*1<1% UR_IJ=+B'8_\R1HC?]()V#/V\XK>D@=O%=14R9: WD![25FK MGQ[MN>7=0>Z)E:"4%FL)XA^L868C\1&S]%#D*I%U4GFYE@?4-T@189:FPUWL M)2,I6Z[57OD98?AUF=YJ%;ICJDA+T,[(/:2G4Y\M-W8@P95]WQ*HJV#.&HV& MYA>H8$Q2J.6Q.YY,;_D>HV3<)D6Z6U]NK:D4HK)H2U!OJ<5C<3=/[I1@";[L M^[9V.5%_XI;A><:'D][I%,ITL;A!/X7C]!')9N85%5J%?0WO$)]%O$"QU$F+ MM34+\B<%)$K=*R7\'PA8 H2!N!?!FXGA0B&T'M,1:*9CQ(6[SP1)!@$O2%C)N M&^TJY^&&2T6^PY$@@&3W-(L5H=" M6"]=TI[NFE2)?P N$UQYNZ&+NI]E]1DWJ4W:Q[^- LGY%2Y(5\"X9:S2($4- MW226"$*1@,G47@G<-7YY]*7.I2&Q H7P75%*,:>VJH\ZXE2KJ=61C=6 ==66 M)F61M6VGWY1,\"-R1(HF B0PSW;17(K]PMX@_'^^O83G@PD D36?DV8D'09^G7+8%/G.<84/D MH0SP0TAIU*PK'G+8$'0H*+%Z?D2R-(>>W?*PK1I:L,UU++*-]56W:G!H'D6V/BFI X- M<%?@T\>3MJ$]W(!S08W'S;9!C-L&6SQDM96W()$&A#B]P>-.<,L.CM7J,HM$ MZJZ"RE76%GK%:;@:O@23#+*B6]N[UJ04[EZ?_%' ;;Y+* N$PG8 .>X"=,F9 MQAI&A) +(L$@EKPC"N&:=#FEV9.K%K4%C#A[O@2)2+:WB6?#16!$H.+J,TK< MZFG5 @19[^REZFAK&VI)4[2% L6#BEU"K9JX+=!7.MS7I4*KT[FS/4EY_DT; M)61)WE(="F?%NE1!EOHM4!>.6'7/M2(A/,NS[(Q2]]#+T\2E/45VH$>C6:CZ M_*/3S%,EI3P_ I2G7K3I5K)$\U6SST0O%8KIYU(%H"[&]#K=G:I2ZY,= MJC2HU_T$MRKA7KJJRV-[W2LC3\//JB )@W4Z:TN2\Y-).Q](ZG3Z4Z;L)Q.@ M/!K3?;>0)_++[=54)*-[X"O2^[,:E#G^NU1%E?0OT$N=Y=US7WH50)9YM8LY M?>UGRCO,]G-_Y2\$S=__+/-.MW#]:7RO:!Y-UNG>\O6B.WBOG(:7-.[0[4G5 M3)/*)X_Z^Y5*]UPI=-U=.Z;E#;P[=/^>UC=0E88#"A@[O1^VJ1N ?JV+%]>( M01?0:G$A>"7[N^K9FZXOL]7R&NN5 9$*8/N;=U_ )==E>_05!P[[Z^QWY<)' MC6_^VXF;H#6_,'/'+JK?X?]90^/KF;6\\W@'KJ+?^I;RM+.N%@?IPJ),GF'/ M$7;J.9,3^<$(9# :@ 7;*'.^CP?,WEOZ#!19<$%\7F/JL %%H7,9<5#Y MK+&6U$A#KJL<7$T0A37A:&6H5.:I^A5[CG)0Y7QE,3?C7XF;J@<94APV09,N M8VJ3*3GGU(SIF?Q*O4C)D=RG&E.T]V(I6N](B&0B%PP-7^3*M7X/*KB\8X+> MO]@NM#Y'"H][S-1^SY34U1_3\UM/3]5P0\S80<_8ZOA&S-6'GJORL$K,TV'/ M4WE$1]C>_?ZM-)HD:/JEMG+5:"K$L@17_89%'403'+W<'(*IWC O M!A %-[TI+H]D"GYZ6[PDG"I(ZLUO53A7,-0;W:LBRH*IWNRN%LP6KMW>^I9' MT 4_O=DM">,+5Y]GE>?Y]7G>?5Y7GV>5Y_GU>=Y]7E>?9Y7G^>5A]GG>6W3$?H\KR[S MO)X]A5+GZG,N 8?G!$Z*>UPI?;A/9[^FDO=Q(WH?Q[794ON)^;T'Y?5^T5 M?NTF./A-5P[2KO(F%#_05?$5CO@FN/B@*Q=*GWX3+!SJRH(T2-"(_:/AKJ\D M]- (!1K:@,J 1B,$:&@.E@=*&F%!6[,P'WMI1'MM[4)Y6*<1#C2T#K.QHD:T MUM >+(:C&M%<0X-0$>UJ1'T-;4!9'*T1W36T_,J"=(TX@30T_59'_AIA0D,+ ML!A(;$1S#4V_7)RR$;4UM/7DD=!JVL=Y%-D\"?%:_ \V[(^IY. MK,4",6C\4?S \TB4AW'R*GKBVW/H6B=_ U!+ 0(4 Q0 ( (*)*UN>;K,H MA14 %N_ 1 " 0 !A8VAV+3(P,C4P.3 U+FAT;5!+ M 0(4 Q0 ( (*)*UMQSBKW7@T +K( 1 " ;05 !A F8VAV+3(P,C4P.3 U+GAS9%!+!08 @ " 'X !!(P ! end XML 12 achv-20250905_htm.xml IDEA: XBRL DOCUMENT 0000949858 dei:OtherAddressMember 2025-09-05 2025-09-05 0000949858 2025-09-05 2025-09-05 0000949858 false 8-K 2025-09-05 ACHIEVE LIFE SCIENCES, INC. DE 033-80623 95-4343413 22722 29th Drive SE Suite 100 Bothell WA 98021 1040 West Georgia Suite 1030 Vancouver BC CA V6E 4H1 604 210-2217 false false false false Common Stock, par value $0.001 per share ACHV NASDAQ false